Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Dagan

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2001
A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriersE Levy-Lahad, A Lahad, S Eisenberg, et al.
British Journal of Cancer|July 30, 2014
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriersT Golan, Z S Kanji, R Epelbaum, et al.
American Journal of Human Genetics|October 3, 1998
Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genesE Friedman, R Bar-Sade Bruchim, A Kruglikova, et al.
Human Mutation|January 11, 2000
Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancerR Shiri-Sverdlov, P Oefner, L Green, et al.
Neurology|February 11, 2012
The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancersR Inzelberg, O S Cohen, J Aharon-Peretz, et al.
British Journal of Cancer|November 19, 2009
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)A Osorio, R L Milne, G Pita, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2001
A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriersE Levy-Lahad, A Lahad, S Eisenberg, et al.
British Journal of Cancer|July 30, 2014
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriersT Golan, Z S Kanji, R Epelbaum, et al.
American Journal of Human Genetics|October 3, 1998
Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genesE Friedman, R Bar-Sade Bruchim, A Kruglikova, et al.
Human Mutation|January 11, 2000
Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancerR Shiri-Sverdlov, P Oefner, L Green, et al.
Neurology|February 11, 2012
The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancersR Inzelberg, O S Cohen, J Aharon-Peretz, et al.
British Journal of Cancer|November 19, 2009
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)A Osorio, R L Milne, G Pita, et al.
Pageof 3